These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10595503)

  • 1. Neurodegenerative tauopathies: human disease and transgenic mouse models.
    Lee VM; Trojanowski JQ
    Neuron; 1999 Nov; 24(3):507-10. PubMed ID: 10595503
    [No Abstract]   [Full Text] [Related]  

  • 2. Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.
    Götz J; Tolnay M; Barmettler R; Chen F; Probst A; Nitsch RM
    Eur J Neurosci; 2001 Jun; 13(11):2131-40. PubMed ID: 11422454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief update on different roles of tau in neurodegeneration.
    Ittner A; Ke YD; van Eersel J; Gladbach A; Götz J; Ittner LM
    IUBMB Life; 2011 Jul; 63(7):495-502. PubMed ID: 21698753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mouse models of tauopathies: prospects for animal models of Pick's disease.
    Lee VM; Trojanowski JQ
    Neurology; 2001 Jun; 56(11 Suppl 4):S26-30. PubMed ID: 11402147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Animal models of tauopathies].
    Higuchi M
    Rinsho Shinkeigaku; 2006 Nov; 46(11):928-30. PubMed ID: 17432223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal Expression of Truncated Tau Efficiently Promotes Neurodegeneration in Animal Models: Pitfalls of Toxic Oligomer Analysis.
    Skrabana R; Kovacech B; Filipcik P; Zilka N; Jadhav S; Smolek T; Kontsekova E; Novak M
    J Alzheimers Dis; 2017; 58(4):1017-1025. PubMed ID: 28527208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau.
    Josephs KA
    Mayo Clin Proc; 2017 Aug; 92(8):1291-1303. PubMed ID: 28778262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain.
    Lim F; Hernández F; Lucas JJ; Gómez-Ramos P; Morán MA; Avila J
    Mol Cell Neurosci; 2001 Dec; 18(6):702-14. PubMed ID: 11749044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of exacerbation of neurodegeneration in a double transgenic mouse model of mutant LRRK2 and tau.
    Mikhail F; Calingasan N; Parolari L; Subramanian A; Yang L; Flint Beal M
    Hum Mol Genet; 2015 Jun; 24(12):3545-56. PubMed ID: 25804954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau in neurodegenerative diseases: tau phosphorylation and assembly.
    Avila J; Pérez M; Lim F; Gómez-Ramos A; Hernández F; Lucas JJ
    Neurotox Res; 2004; 6(6):477-82. PubMed ID: 15639780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Following the leader: fibrillization of alpha-synuclein and tau.
    Frasier M; Wolozin B
    Exp Neurol; 2004 Jun; 187(2):235-9. PubMed ID: 15144849
    [No Abstract]   [Full Text] [Related]  

  • 12. Tau kinase I overexpression induces dentate gyrus degeneration.
    Avila J; Gómez de Barreda E; Engel T; Pérez M; Martín-Maestro P; Fuster-Matanzo A; Goñi-Oliver P; Lucas JJ; Hernández F
    Neurodegener Dis; 2010; 7(1-3):13-5. PubMed ID: 20160451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic zebrafish as a novel animal model to study tauopathies and other neurodegenerative disorders in vivo.
    Paquet D; Schmid B; Haass C
    Neurodegener Dis; 2010; 7(1-3):99-102. PubMed ID: 20173336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling early responses to neurodegenerative mutations in mice.
    Gilley J; Adalbert R; Coleman MP
    Biochem Soc Trans; 2011 Aug; 39(4):933-8. PubMed ID: 21787326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau and axonopathy in neurodegenerative disorders.
    Higuchi M; Lee VM; Trojanowski JQ
    Neuromolecular Med; 2002; 2(2):131-50. PubMed ID: 12428808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathological characterization of two siblings carrying the MAPT S305S mutation demonstrates features resembling argyrophilic grain disease.
    Rönnbäck A; Nennesmo I; Tuominen H; Grueninger F; Viitanen M; Graff C
    Acta Neuropathol; 2014 Feb; 127(2):297-8. PubMed ID: 24337498
    [No Abstract]   [Full Text] [Related]  

  • 17. Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau.
    Tanemura K; Akagi T; Murayama M; Kikuchi N; Murayama O; Hashikawa T; Yoshiike Y; Park JM; Matsuda K; Nakao S; Sun X; Sato S; Yamaguchi H; Takashima A
    Neurobiol Dis; 2001 Dec; 8(6):1036-45. PubMed ID: 11741399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditionally inducible tau mice--designing a better mouse model of neurodegenerative diseases.
    Janus C
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():12-27. PubMed ID: 18184367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cyclophilin 40 unravels neurotoxic amyloids.
    Baker JD; Shelton LB; Zheng D; Favretto F; Nordhues BA; Darling A; Sullivan LE; Sun Z; Solanki PK; Martin MD; Suntharalingam A; Sabbagh JJ; Becker S; Mandelkow E; Uversky VN; Zweckstetter M; Dickey CA; Koren J; Blair LJ
    PLoS Biol; 2017 Jun; 15(6):e2001336. PubMed ID: 28654636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau pathology: a marker of neurodegenerative disorders.
    Delacourte A; Buée L
    Curr Opin Neurol; 2000 Aug; 13(4):371-6. PubMed ID: 10970052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.